RadNet Crecimiento futuro
Future controles de criterios 4/6
Se prevé un crecimiento anual de los beneficios y los ingresos de RadNet de 81.7% y 12.3% respectivamente, mientras que el BPA crecerá en un 81.6% al año.
Información clave
81.7%
Tasa de crecimiento de los beneficios
81.56%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Healthcare | 17.9% |
| Tasa de crecimiento de los ingresos | 12.3% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Good |
| Última actualización | 11 May 2026 |
Actualizaciones recientes sobre el crecimiento futuro
Artículo de análisis • Nov 14
Earnings Miss: RadNet, Inc. Missed EPS By 65% And Analysts Are Revising Their Forecasts
Shareholders might have noticed that RadNet, Inc. ( NASDAQ:RDNT ) filed its third-quarter result this time last week...Artículo de análisis • May 15
RadNet, Inc. (NASDAQ:RDNT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Investors in RadNet, Inc. ( NASDAQ:RDNT ) had a good week, as its shares rose 9.8% to close at US$60.34 following the...Recent updates
Actualización del análisis • May 07
RDNT: Imaging Platform Execution And New Idaho Venture Will Support Future Earnings
Analysts have trimmed their fair value estimate for RadNet by $0.50 to $89.88, reflecting updated assumptions around discount rate, revenue growth, profit margin, and future P/E after recent Street research, including a lower $4 price target from B. Riley and an upgrade of Lumexa Imaging at Raymond James.Actualización del análisis • Apr 23
RDNT: Sector Sentiment Tailwinds Will Support Future Earnings Visibility
Analysts have trimmed their price target on RadNet by $2 to reflect slightly updated assumptions on fair value, future P/E and operating metrics, while incorporating recent Street research that highlights improved sentiment following the Raymond James upgrade of Lumexa Imaging. Analyst Commentary Bullish Takeaways Bullish analysts view the recent upgrade of Lumexa Imaging as a supportive read-through for sentiment around diagnostic imaging.Actualización del análisis • Apr 08
RDNT: Outpatient Imaging Shift Will Support Future Earnings Visibility
RadNet's analyst price target now stands at $92. Analysts cite outpatient diagnostic imaging growth drivers, Medicare reimbursement support, potential capital deployment, and an AI ramp as key reasons for maintaining this level.Actualización del análisis • Mar 25
RDNT: Outpatient Imaging Shift And AI Adoption Will Drive Future Upside
Analysts kept their $92 price target for RadNet unchanged, citing what they see as attractive long term growth drivers in outpatient diagnostic imaging, reasonable 2025 to 2028 company targets, supportive Medicare reimbursement trends, potential capital deployment benefits, and expected AI contributions. Analyst Commentary Bullish Takeaways Bullish analysts view outpatient diagnostic imaging as an attractive subsector, with hospital to outpatient shifts and growing demand for advanced imaging seen as key growth drivers that support RadNet's long term story and current valuation framework.Actualización del análisis • Mar 09
RDNT: Outpatient Imaging Shift And AI Ramp Will Support Future Upside
Analysts have raised their price target on RadNet from $91.75 to $92.38. The updated target reflects revised assumptions that incorporate higher projected revenue growth, a lower profit margin outlook, and a higher future P/E multiple supported by recent bullish Street research on outpatient imaging and AI benefits.Actualización del análisis • Feb 22
RDNT: Outpatient Imaging Shift And AI Adoption Will Support Future Upside
Analysts have trimmed their implied future P/E assumption for RadNet, leading to a slightly lower blended price target of about $97 vs. roughly $102 previously.Actualización del análisis • Feb 08
RDNT: Outpatient Imaging Shift And AI Breast Screening Will Support Upside
Analysts have raised their price target on RadNet to about $92, reflecting confidence in the outpatient diagnostic imaging segment and the company's 2025 to 2028 targets, including expected benefits from improved Medicare rates, potential capital deployment, and increasing AI contributions. Analyst Commentary Recent research reflects a generally constructive tone on RadNet, with several firms lifting price targets into the high US$80s to low US$90s range and highlighting both the core imaging business and longer term AI potential.Actualización del análisis • Jan 24
RDNT: Outpatient Imaging Shift And AI Breast Screening Will Drive Upside
Analysts lifted their price target on RadNet to about US$91.75 from roughly US$91.71, reflecting recent coverage that highlights outpatient imaging growth drivers, supportive Medicare reimbursement, capital deployment options, and potential contributions from artificial intelligence (AI). Analyst Commentary Recent Street research on RadNet focuses on outpatient imaging growth, long term targets and the role of AI and capital allocation in supporting the current valuation framework.Actualización del análisis • Jan 09
RDNT: Outpatient Imaging And AI Adoption Will Drive Future Outperformance
Analysts have raised their price target on RadNet to about US$92, citing what they view as reasonable 2025 to 2028 goals, supportive Medicare reimbursement trends, potential capital deployment upside, and growing contributions from AI and outpatient imaging demand. Analyst Commentary Recent research has focused on how RadNet's outpatient imaging footprint, AI initiatives, and long term financial targets could support its valuation and growth ambitions.Actualización del análisis • Dec 13
RDNT: Integrated Offerings And Margin Expansion Will Drive Future Outperformance
Analysts have modestly increased their price target on RadNet, citing stronger long term growth and margin expansion prospects highlighted at the recent investor day and reflected in updated fair value estimates rising from about $91.71 to roughly $92.50 per share, alongside reaffirmed expectations for double digit revenue growth and mid teens EBITDA expansion. Analyst Commentary Bullish analysts highlight that the updated 2028 targets for double digit revenue growth and margin expansion underpin a durable mid teens EBITDA growth profile, which they view as supportive of further multiple expansion from current levels.Actualización del análisis • Nov 28
RDNT: Sustained Demand And Integrated Offerings Will Drive Future Outperformance
Analysts have raised their price target for RadNet from approximately $87 to $93, citing higher revenue growth expectations and confidence in the company’s integrated offerings and sustained demand. Analyst Commentary Bullish Takeaways Bullish analysts have raised price targets for RadNet, citing encouraging revenue growth expectations and confidence in the company’s ability to deliver sustained margin expansion.Artículo de análisis • Nov 14
Earnings Miss: RadNet, Inc. Missed EPS By 65% And Analysts Are Revising Their Forecasts
Shareholders might have noticed that RadNet, Inc. ( NASDAQ:RDNT ) filed its third-quarter result this time last week...Actualización del análisis • Nov 13
RDNT: Momentum Will Accelerate From Surging Demand And Integrated Offerings
RadNet’s analyst price target has increased from $80.57 to $86.67. This reflects confidence from analysts who cite strong demand, integrated offerings, and positive industry momentum as key drivers.Actualización del análisis • Oct 30
RDNT: Imaging Center Demand And Digital Health Will Drive Measured Upside Potential
Analysts have increased their price target for RadNet from $74 to $81. They cite strong core imaging center demand and ongoing investments in digital health as key factors for the optimistic outlook.Actualización del análisis • Oct 15
AI Powered Imaging And Demographic Trends Will Accelerate Advanced Diagnostics
RadNet's analyst price target has been raised from $79.29 to $80.57 per share. This change reflects analysts' optimism amid strong imaging center demand, ongoing digital health investments, and potential M&A opportunities.Actualización del análisis • Sep 19
AI Powered Imaging And Demographic Trends Will Accelerate Advanced Diagnostics
RadNet’s consensus price target has risen to $79.29 as analysts cite robust imaging center demand, expanding service opportunities, strong digital health investments, and confidence in management’s strategic execution. Analyst Commentary Robust core imaging center demand trends indicate sustained growth potential.Artículo de análisis • Sep 12
RadNet (NASDAQ:RDNT) Takes On Some Risk With Its Use Of Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Actualización del análisis • Sep 04
AI Powered Imaging And Demographic Trends Will Accelerate Advanced Diagnostics
Driven by robust imaging center demand, growth opportunities, and strong digital health investments, RadNet’s consensus analyst price target held steady at $77.43. Analyst Commentary Robust core imaging center demand trends highlighted in recent management meetings.Seeking Alpha • Aug 18
RadNet: Bloated Capital Base Not Pulling Its Economic Weight (Rating Downgrade)
Summary I am downgrading RDNT stock to hold due to excessive capital requirements, bloated acquisitions, and declining returns on invested capital despite strong top-line growth. The valuation is stretched, with RadNet trading at 78x EBIT and >5x book value, while debt levels and working capital intensity have surged. Operating margins are compressing, free cash flow yields have turned negative, and acquisitions are not delivering sufficient economic returns. I will reconsider a more bullish stance only if RDNT demonstrates margin expansion, improved capital productivity, or stronger free cash flow generation. Read the full article on Seeking AlphaArtículo de análisis • Jul 31
Some Confidence Is Lacking In RadNet, Inc.'s (NASDAQ:RDNT) P/S
When close to half the companies in the Healthcare industry in the United States have price-to-sales ratios (or "P/S...Artículo de análisis • Jul 15
RadNet (NASDAQ:RDNT) May Have Issues Allocating Its Capital
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Artículo de análisis • Jun 10
We Think RadNet (NASDAQ:RDNT) Is Taking Some Risk With Its Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Artículo de análisis • May 15
RadNet, Inc. (NASDAQ:RDNT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Investors in RadNet, Inc. ( NASDAQ:RDNT ) had a good week, as its shares rose 9.8% to close at US$60.34 following the...Artículo de análisis • May 07
Is There An Opportunity With RadNet, Inc.'s (NASDAQ:RDNT) 37% Undervaluation?
Key Insights The projected fair value for RadNet is US$84.18 based on 2 Stage Free Cash Flow to Equity Current share...Artículo de análisis • Apr 24
Is RadNet, Inc. (NASDAQ:RDNT) Potentially Undervalued?
RadNet, Inc. ( NASDAQ:RDNT ), might not be a large cap stock, but it received a lot of attention from a substantial...Artículo de análisis • Apr 11
Returns On Capital Signal Tricky Times Ahead For RadNet (NASDAQ:RDNT)
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Seeking Alpha • Mar 11
RadNet: On The Sidelines For Now
Summary RDNT's stock performance has been lackluster, with only an 8.8% increase over the past year, currently trading at $50 per share. Despite decent fundamentals, including steady revenue growth and strong operating cash flow, RDNT faces risks from wage increases and weather-related disruptions. Recent market overreaction to temporary weather impacts presents a potential rebound opportunity, but the projected 8.6% return does not justify the investment risk. I rate RDNT as neutral due to uncertainties in revenue growth and bottom-line pressures, suggesting better opportunities elsewhere with more favorable risk-reward profiles. Read the full article on Seeking AlphaArtículo de análisis • Feb 16
There's Reason For Concern Over RadNet, Inc.'s (NASDAQ:RDNT) Price
RadNet, Inc.'s ( NASDAQ:RDNT ) price-to-sales (or "P/S") ratio of 2.6x may not look like an appealing investment...Artículo de análisis • Jan 31
A Look At The Fair Value Of RadNet, Inc. (NASDAQ:RDNT)
Key Insights RadNet's estimated fair value is US$73.25 based on 2 Stage Free Cash Flow to Equity Current share price of...Artículo de análisis • Jan 16
Does RadNet (NASDAQ:RDNT) Have A Healthy Balance Sheet?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Artículo de análisis • Jan 01
Is It Time To Consider Buying RadNet, Inc. (NASDAQ:RDNT)?
RadNet, Inc. ( NASDAQ:RDNT ), might not be a large cap stock, but it received a lot of attention from a substantial...Artículo de análisis • Nov 12
There's Reason For Concern Over RadNet, Inc.'s (NASDAQ:RDNT) Massive 26% Price Jump
RadNet, Inc. ( NASDAQ:RDNT ) shares have continued their recent momentum with a 26% gain in the last month alone. The...Artículo de análisis • Oct 15
Here's What To Make Of RadNet's (NASDAQ:RDNT) Decelerating Rates Of Return
If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...Seeking Alpha • Oct 02
RadNet: Secular Tailwinds Underpinned By AI Monetization Prospects
Summary RadNet, the largest US diagnostic imaging operator, projects $1.8bn in 2024 revenue, driven by AI and Digital Health growth, and expanding imaging centers. Strong Q2 results with 13.9% revenue growth and 19.7% EBITDA increase, fueled by AI advancements and new imaging center openings. Future growth catalysts include market shifts to freestanding centers, increasing importance of joint ventures, and capital deployment for acquisitions and new facilities. Digital Health and AI initiatives, like DeepHealth OS and EBCD, are expected to drive significant revenue and margin expansion. Read the full article on Seeking AlphaArtículo de análisis • Sep 22
Unpleasant Surprises Could Be In Store For RadNet, Inc.'s (NASDAQ:RDNT) Shares
When close to half the companies in the Healthcare industry in the United States have price-to-sales ratios (or "P/S...
Nuevo análisis • Aug 30
Expanding Imaging Modalities And AI Integration Signal Strong Future Growth In Healthcare Sector
Expansion into advanced imaging and integration of AI technologies aim at boosting revenue through higher reimbursement rates and operational efficiencies.Seeking Alpha • Aug 24
RadNet: Growth In Operating Earnings Off Very Little Incremental Capital
Summary RDNT stock is up 10% since my June publication following a strong set of quarterly numbers in its Q2 FY'24 earnings. Management continue executing on the growth route, recycling funds into new store openings. Same-store procedure volumes continue to ratchet higher, evidencing increased utilization of its legacy base. Net-net, reiterate buy. Read the full article on Seeking AlphaArtículo de análisis • Jul 22
RadNet (NASDAQ:RDNT) Seems To Use Debt Quite Sensibly
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Artículo de análisis • Jun 05
Returns On Capital At RadNet (NASDAQ:RDNT) Have Stalled
To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...Seeking Alpha • Jun 05
RadNet: Qualified Growth Route, Still Undervalued
Summary RadNet, Inc. shares continue to show strength, having compounded by 184% since 2022. Q1 FY 2024 earnings showed growth in the Digital Health segment and increased MRI, CT, and PET/CT volumes. Management has increased its outlook on full-year revenues and projects $1.67-$1.7 billion in revenue for the year. Read the full article on Seeking AlphaArtículo de análisis • May 10
Is There Now An Opportunity In RadNet, Inc. (NASDAQ:RDNT)?
While RadNet, Inc. ( NASDAQ:RDNT ) might not have the largest market cap around , it received a lot of attention from a...Artículo de análisis • Apr 08
Are RadNet, Inc. (NASDAQ:RDNT) Investors Paying Above The Intrinsic Value?
Key Insights Using the 2 Stage Free Cash Flow to Equity, RadNet fair value estimate is US$40.76 RadNet's US$49.04 share...Artículo de análisis • Mar 06
RadNet, Inc.'s (NASDAQ:RDNT) 26% Price Boost Is Out Of Tune With Revenues
The RadNet, Inc. ( NASDAQ:RDNT ) share price has done very well over the last month, posting an excellent gain of 26...Artículo de análisis • Feb 08
Why RadNet, Inc. (NASDAQ:RDNT) Could Be Worth Watching
RadNet, Inc. ( NASDAQ:RDNT ), might not be a large cap stock, but it received a lot of attention from a substantial...Seeking Alpha • Jan 28
RadNet, Inc. Stock Price Is More Vigorous Than Its Valuation
Summary RadNet, Inc. is assessed as a Buy opportunity especially on price dips for retail value investors; watch its valuation and growth ratings. The company's share price has seen significant growth recently but may drop due to volatility and potential missed estimates. RadNet is at the forefront of the movement to bring diagnostic imaging services out of hospitals, offering lower costs and increased accessibility. Read the full article on Seeking AlphaArtículo de análisis • Dec 28
Getting In Cheap On RadNet, Inc. (NASDAQ:RDNT) Might Be Difficult
There wouldn't be many who think RadNet, Inc.'s ( NASDAQ:RDNT ) price-to-sales (or "P/S") ratio of 1.5x is worth a...Artículo de análisis • Dec 04
We Think RadNet (NASDAQ:RDNT) Can Stay On Top Of Its Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Artículo de análisis • Aug 27
RadNet (NASDAQ:RDNT) Might Be Having Difficulty Using Its Capital Effectively
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd...Artículo de análisis • Aug 09
RadNet (NASDAQ:RDNT) Takes On Some Risk With Its Use Of Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Artículo de análisis • Mar 30
We Think RadNet (NASDAQ:RDNT) Is Taking Some Risk With Its Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Artículo de análisis • Feb 19
RadNet (NASDAQ:RDNT) Will Want To Turn Around Its Return Trends
There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2028 | 3,049 | 79 | 191 | 470 | 4 |
| 12/31/2027 | 2,723 | 66 | 138 | 343 | 5 |
| 12/31/2026 | 2,475 | 20 | 80 | 274 | 6 |
| 3/31/2026 | 2,144 | -14 | 102 | 336 | N/A |
| 12/31/2025 | 2,040 | -19 | 86 | 299 | N/A |
| 9/30/2025 | 1,970 | -13 | 52 | 257 | N/A |
| 6/30/2025 | 1,908 | -15 | 76 | 262 | N/A |
| 3/31/2025 | 1,869 | -32 | 78 | 257 | N/A |
| 12/31/2024 | 1,830 | 3 | 45 | 233 | N/A |
| 9/30/2024 | 1,773 | -4 | 94 | 279 | N/A |
| 6/30/2024 | 1,714 | 10 | 68 | 253 | N/A |
| 3/31/2024 | 1,658 | 21 | 27 | 205 | N/A |
| 12/31/2023 | 1,617 | 3 | 44 | 221 | N/A |
| 9/30/2023 | 1,580 | 4 | 28 | 186 | N/A |
| 6/30/2023 | 1,528 | -13 | 39 | 181 | N/A |
| 3/31/2023 | 1,479 | -13 | 39 | 178 | N/A |
| 12/31/2022 | 1,430 | 11 | 27 | 146 | N/A |
| 9/30/2022 | 1,382 | 8 | -11 | 142 | N/A |
| 6/30/2022 | 1,365 | 23 | -5 | 157 | N/A |
| 3/31/2022 | 1,344 | 18 | -27 | 122 | N/A |
| 12/31/2021 | 1,324 | 25 | 6 | 149 | N/A |
| 9/30/2021 | 1,297 | 35 | 58 | 164 | N/A |
| 6/30/2021 | 1,256 | 24 | 77 | 161 | N/A |
| 3/31/2021 | 1,138 | 11 | 148 | 221 | N/A |
| 12/31/2020 | 1,098 | -15 | 140 | 234 | N/A |
| 9/30/2020 | 1,090 | -10 | 109 | 192 | N/A |
| 6/30/2020 | 1,091 | -13 | 103 | 191 | N/A |
| 3/31/2020 | 1,164 | 2 | 26 | 118 | N/A |
| 12/31/2019 | 1,154 | 15 | N/A | 104 | N/A |
| 9/30/2019 | 1,111 | 33 | N/A | 111 | N/A |
| 6/30/2019 | 1,060 | 35 | N/A | 114 | N/A |
| 3/31/2019 | 1,015 | 36 | N/A | 119 | N/A |
| 12/31/2018 | 975 | 32 | N/A | 117 | N/A |
| 9/30/2018 | 953 | -4 | N/A | 154 | N/A |
| 6/30/2018 | 939 | -6 | N/A | 139 | N/A |
| 3/31/2018 | 925 | -6 | N/A | 136 | N/A |
| 12/31/2017 | 922 | 0 | N/A | 142 | N/A |
| 9/30/2017 | 912 | 11 | N/A | 112 | N/A |
| 6/30/2017 | 909 | 9 | N/A | 90 | N/A |
| 3/31/2017 | 897 | 7 | N/A | 102 | N/A |
| 12/31/2016 | 885 | 7 | N/A | 92 | N/A |
| 9/30/2016 | 875 | 5 | N/A | 82 | N/A |
| 6/30/2016 | 859 | 11 | N/A | 91 | N/A |
| 3/31/2016 | 845 | 11 | N/A | 71 | N/A |
| 12/31/2015 | 810 | 8 | N/A | 67 | N/A |
| 9/30/2015 | 779 | 11 | N/A | 67 | N/A |
| 6/30/2015 | 755 | 7 | N/A | 69 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Se prevé que RDNT sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (3.5%).
Beneficios vs. Mercado: Se prevé que RDNT sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.
Beneficios de alto crecimiento: Se espera que RDNT sea rentable en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (12.3% al año) de RDNT crezcan más rápidamente que los del mercado US (11.6% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 12.3% al año) de RDNT crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de RDNT se prevé que sea elevada dentro de 3 años.
Descubre empresas en crecimiento
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/11 05:21 |
| Precio de las acciones al final del día | 2026/05/11 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
RadNet, Inc. está cubierta por 12 analistas. 6 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Sarah James | Barclays |
| Andrew Mok | Barclays |
| Yuan Zhi | B. Riley Securities, Inc. |